Creese I[au] - Search Results

Year	Number of Results
1972	1
1973	1
1974	2
1975	9
1976	7
1977	6
1978	7
1979	11
1980	11
1981	7
1982	12
1983	10
1984	5
1985	8
1986	14
1987	5
1988	3
1989	3
1990	1
1991	2
1992	3
1993	1
1994	2
1995	1
1996	2
1997	5
1998	1
1999	2
2000	1
2001	1
2021	0

1

Dopamine receptors: subtypes, localization and regulation.

Creese I, Sibley DR, Leff S, Hamblin M. Creese I, et al. Fed Proc. 1981 Feb;40(2):147-52. Fed Proc. 1981. PMID: 7007083 Review.

2

The classification of dopamine receptors: relationship to radioligand binding.

Creese I, Sibley DR, Hamblin MW, Leff SE. Creese I, et al. Annu Rev Neurosci. 1983;6:43-71. doi: 10.1146/annurev.ne.06.030183.000355. Annu Rev Neurosci. 1983. PMID: 6220666 Review. No abstract available.

3

Classification of dopamine receptors.

Creese I, Sibley DR, Leff S. Creese I, et al. Adv Biochem Psychopharmacol. 1983;37:255-66. Adv Biochem Psychopharmacol. 1983. PMID: 6416028 Review. No abstract available.

4

Biochemical and behavioral studies of D1 dopamine receptors utilizing SCH 23390.

Hess EJ, Creese I. Hess EJ, et al. Among authors: creese i. Adv Exp Med Biol. 1986;204:29-52. doi: 10.1007/978-1-4684-5191-7_3. Adv Exp Med Biol. 1986. PMID: 2878579 Review. No abstract available.

5

Dopamine receptor subtype imbalance in schizophrenia.

Hess EJ, Bracha HS, Kleinman JE, Creese I. Hess EJ, et al. Among authors: creese i. Life Sci. 1987 Apr 13;40(15):1487-97. doi: 10.1016/0024-3205(87)90381-x. Life Sci. 1987. PMID: 2951573

6

Butyrophenone influences on the opiate receptor.

Creese I, Feinberg AP, Snyder SH. Creese I, et al. Eur J Pharmacol. 1976 Mar;36(1):231-5. doi: 10.1016/0014-2999(76)90277-6. Eur J Pharmacol. 1976. PMID: 1261596

7

Dopamine receptors and average clinical doses.

Creese I, Burt DR, Snyder SH. Creese I, et al. Science. 1976 Oct 29;194(4264):546. doi: 10.1126/science.194.4264.546. Science. 1976. PMID: 17783671 No abstract available.

8

Receptor adaptations to centrally acting drugs.

Creese I, Sibley DR. Creese I, et al. Annu Rev Pharmacol Toxicol. 1981;21:357-91. doi: 10.1146/annurev.pa.21.040181.002041. Annu Rev Pharmacol Toxicol. 1981. PMID: 6263174 Review. No abstract available.

9

Reduction in muscarinic receptors by antisense oligodeoxynucleotide.

Zang Z, Florijn W, Creese I. Zang Z, et al. Among authors: creese i. Biochem Pharmacol. 1994 Jul 19;48(2):225-8. doi: 10.1016/0006-2952(94)90090-6. Biochem Pharmacol. 1994. PMID: 8053918

10

Guanine nucleotides distinguish between two dopamine receptors.

Creese I, Usdin T, Snyder SH. Creese I, et al. Nature. 1979 Apr 5;278(5704):577-8. doi: 10.1038/278577a0. Nature. 1979. PMID: 431724 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results